Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure - Takeaways - MDSpire

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

  • By

  • Ramzi Ibrahim

  • Luke Dreher

  • Hussein Abdul Nabi

  • Juan Maria Farina

  • Eiad Habib

  • Hoang Nhat Pham

  • Min Choon Tan

  • Hussein A. Noureldine

  • Sammudeen Ibrahim

  • Mayurkumar Bhakta

  • Kwan Lee

  • Dan Sorajja

  • Win-Kuang Shen

  • Luis R. Scott

  • Chadi Ayoub

  • Reza Arsanjani

  • Hicham Z. El Masry

  • May 26, 2026

  • 0 min

Share

  • 1

    Elevated lipoprotein(a) [Lp(a)] levels are linked to increased risk of treated ventricular arrhythmias in heart failure patients.

  • 2

    In a study of 595 heart failure patients, 25.8% with elevated Lp(a) received appropriate ICD shocks compared to 9.6% with lower levels.

  • 3

    The study found no significant difference in all-cause mortality between patients with elevated and lower Lp(a) levels.

  • 4

    Elevated Lp(a) was associated with a higher rate of appropriate shocks and ATP-treated events, indicating arrhythmia risk.

  • 5

    The findings suggest elevated Lp(a) may identify an arrhythmia-prone phenotype in heart failure with reduced ejection fraction.

Original Source(s)

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

  • by Ramzi Ibrahim, Luke Dreher, Hussein Abdul Nabi, Juan Maria Farina, Eiad Habib, Hoang Nhat Pham, Min Choon Tan, Hussein A. Noureldine, Sammudeen Ibrahim, Mayurkumar Bhakta, Kwan Lee, Dan Sorajja, Win-Kuang Shen, Luis R. Scott, Chadi Ayoub, Reza Arsanjani, Hicham Z. El Masry

  • May 26, 2026

Related Content

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention

Thoracoscopically assisted resection of left ventricular myxoma: a case report

Recognizing the Transition to Advanced Heart Failure Earlier

Despite major advances in guideline-directed medical therapy (GDMT), worsening heart failure continues to drive significant morbidity, repeat hospitalizations and healthcare utilization worldwide.

  • by

  • May 27, 2026

  • 6 min